Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Galectin Therapeutics Inc.

TRADE

NASDAQ: GALTHealthcare / Drugs - Generic / USA
7.67-0.04-0.52%Vol 663 6041Y Perf 220.17%
Jun 22nd, 2018 16:00
BID7.20 ASK8.76
Open7.65 Previous Close7.71
Pre-Market7.50 After-Trading-
 -0.21 -2.72%  - -%
Target Price
8.33 
Analyst Rating
Strong Buy 1.00
Potencial %
8.60 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-94/-76 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-99 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-100/-100/-98 
Income Ranking
 —    -
Market Cap (mil)288 
Earnings Rating
Sell
Price Range Ratio 52wk %
77.83 
Earnings Date
13th Aug 2018

Today's Price Range

7.517.97

 

52wk Range

1.289.49

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
88.92%
3 Months
65.30%
6 Months
197.29%
1 Year
220.17%
3 Years
153.97%
5 Years
89.38%

Quotes

Name / TickerPriceChg.Chg.%
GALT7.67-0.0400-0.52
AAPL184.92-0.5400-0.29
GOOG1 155.48-2.1800-0.19
MSFT100.41-0.7300-0.72
XOM81.381.69002.12
WFC53.94-0.4300-0.79
JNJ122.841.39001.14
FB201.740.24000.12
GE13.050.29002.27
JPM105.75-1.7600-1.64
...

TickerPriceChg.%52 Week High
KMX80.1912.8681.67
MRO21.487.8322.12
APC74.116.6974.72
PCG42.925.9071.57
PDCO24.625.7648.29
NFX30.755.2035.20
DVN43.285.1845.16
FTI32.345.1435.00
HES64.574.6365.89
PXD185.654.29213.40
XEC97.694.18130.16
COP67.784.1071.71
SWN5.473.806.72
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.70
Current Ratio 2.00
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -161.00
Leverage Ratio -1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 103.91
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -21.20
Cash Flow Per Share -0.43
Price to Tangible Book-52.30
Book Value per Share-0.17
Enterprise Value (in ths.)333 482
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-273.92
ROE last 12 Months 607.06
Return on Assets (5Y Avg) -198.96
ROA last 12 Months -159.03
Return on Capital (5Y Avg) -235.29
ROC last 12 Months -280.09
Return on invested Capital Q -280.09
Return on invested Capital Y-218.11
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.13-0.127.69
Q04 2017-0.11-0.0736.36
Q03 2017-0.14-0.137.14
Q02 2017-0.15-0.146.67
Q01 2017-0.15-0.150.00
Q04 2016-0.16-0.1318.75
Q03 2016-0.22-0.1913.64
Q02 2016-0.27-0.2025.93
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.14-7.69Negative
9/2018 QR-0.11-10.00Negative
12/2018 FY-0.50-4.17Negative
12/2019 FY-0.78-13.04Negative
Next Report Date13th Aug 2018
Estimated EPS Next Report-0.14
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume663 604
Shares Outstanding (in ths.)37 570
Trades Count2 071
Dollar Volume4 742 809
Avg. Volume751 590
Avg. Weekly Volume1 814 307
Avg. Monthly Volume1 456 847
Avg. Quarterly Volume817 276

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

69%31%

Bearish Bullish

59%41%

Bearish Bullish

59%41%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x